As flu season ramps up, everyone’s keeping their eyes on COVID-19 numbers, especially patients with neurologic disease and the doctors who treat them. Every day our understanding of how the pandemic impacts these patients becomes clearer, and the image is pretty scary—fitting for the Halloween season. This week we offer insights into how the pandemic…

World Alzheimer’s Day arrived last week and brought with it a host of new research into the world’s most common form of dementia. We’re celebrating with an influx of new dementia insights, including the condition’s ancient history, two new cutting-edge biomarkers, and a pandemic-related condition that doubles its risk. Plus, shocking new data on your…

Between a brand new class of drugs, revelations about ties to pregnancy, updates on off-label drug use, and a slew of new data on disease-modifying therapies, it was a fast-paced week in the world of multiple sclerosis. We’ll keep you abreast of the latest breakthroughs, plus many more from across the world of neurology—like new…

COVID-19 got in the way of a lot of big plans, like that fitness routine that we totally would’ve gotten around to if the gym had been open. It also put the brakes on tons of sorely-needed scientific research. But the show must go on, and this week we find that things are looking especially…

It’s not often that the worlds of neurology, pulmonology, and oncology come together all at once, but this week, we’re bringing you a story that makes it happen, with an interesting set of benefits for all three specialties. That’s not all, though—we’ve got brand new bona fides for one of the most-prescribed migraine drugs, new…